First Time Loading...

Anebulo Pharmaceuticals Inc
NASDAQ:ANEB

Watchlist Manager
Anebulo Pharmaceuticals Inc Logo
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
Watchlist
Price: 2.08 USD -1.65% Market Closed
Updated: May 29, 2024

Anebulo Pharmaceuticals Inc
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Anebulo Pharmaceuticals Inc
Total Assets Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
Total Assets
$11.7m
CAGR 3-Years
57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Assets
$172B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Total Assets
$99B
CAGR 3-Years
-4%
CAGR 5-Years
23%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Total Assets
$221.1B
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
3%
Merck & Co Inc
NYSE:MRK
Total Assets
$105.8B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Total Assets
$63.9B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
6%

See Also

What is Anebulo Pharmaceuticals Inc's Total Assets?
Total Assets
11.7m USD

Based on the financial report for Jun 30, 2023, Anebulo Pharmaceuticals Inc's Total Assets amounts to 11.7m USD.

What is Anebulo Pharmaceuticals Inc's Total Assets growth rate?
Total Assets CAGR 3Y
57%

Over the last year, the Total Assets growth was -25%. The average annual Total Assets growth rates for Anebulo Pharmaceuticals Inc have been 57% over the past three years .